Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...

ROCK star David Roach has been diagnosed with a “very aggressive” form of cancer after symptoms of a “fever and a cough”. The ...

During a live event, Neal E. Ready, MD, and participants discussed what factors justify using PD-1 plus CTLA-4 inhibitor and ...

It's incredibly scary to experience a random symptom out of nowhere, especially when it won't go away. So when I saw Reddit ...

A new legal campaign, led by Top 100 UK law firm Hugh James, is calling on former workers of the Avenue Tar Plant, and the ...

Have you ever heard about a cancer that is "in situ"? There's a reason why it's called that -- and why it's the kind of ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

Glenmark Pharmaceuticals share price gained in trade after the company announced the launch of Tevimbra (tislelizumab) in ...

GS-1811, a potential first-in-class immunotherapy, is designed to target and deplete immunosuppressive Tregs in the tumor ...

Regeneron Pharmaceuticals, Inc. faces challenges with Eylea sales but sees growth from Dupixent and obesity drugs. Click for ...